Intracerebral or systemic injections of structurally distinct alpha-synuclein amyloids into experimental animals gave rise to different neuropathology with features that resemble Parkinson’s disease (PD) and multiple system atrophy (MSA) [50]. This evidence concerns the gene SNCA and multiple system atrophy.